| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
Total
2
4'-Methoxychalcone
4'-Methoxychalcone is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 41 references associated with 4'-Methoxychalcone in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 4'-Methoxychalcone
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 4'-Methoxychalcone
NCBI Entrez Crosslinks
All references with 4'-Methoxychalcone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hsieh CT et al. | 2-Bromo-4'-methoxychalcone and 2-Iodo-4'-methoxychalcone Prevent Progression of Hyperglycemia and Obesity via 5'-Adenosine-Monophosphate-Activated Protein Kinase in Diet-Induced Obese Mice. | 2018 | Int J Mol Sci | pmid:30223438 |
| Han Y et al. | Regulatory effects of 4-methoxychalcone on adipocyte differentiation through PPARγ activation and reverse effect on TNF-α in 3T3-L1 cells. | 2017 | Food Chem. Toxicol. | pmid:28528971 |
| Shakil NA et al. | Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives. | 2013 | Eur J Med Chem | pmid:23229055 |
| Lim J et al. | 4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells. | 2013 | Mol. Cells | pmid:24046186 |
| Kim YS et al. | Methoxychalcone inhibitors of androgen receptor translocation and function. | 2012 | Bioorg. Med. Chem. Lett. | pmid:22310230 |
| Kumar V et al. | Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells. | 2011 | J. Med. Chem. | pmid:21539383 |
| Burns AR et al. | A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans. | 2010 | Nat. Chem. Biol. | pmid:20512140 |
| Montes-Avila J et al. | Solution-phase parallel synthesis of substituted chalcones and their antiparasitary activity against Giardia lamblia. | 2009 | Bioorg. Med. Chem. | pmid:19683930 |
| Souza AM et al. | Leishmania amazonensis growth inhibitors: biological and theoretical features of sulfonamide 4-methoxychalcone derivatives. | 2009 | Curr. Microbiol. | pmid:19629593 |
| Meng CQ et al. | Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression. | 2004 | Bioorg. Med. Chem. Lett. | pmid:15006393 |